• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . SARS-CoV-2 reinfection associates with unstable housing and occurs in the presence of antibodies

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2021 Nov 10;ciab940.
doi: 10.1093/cid/ciab940. Online ahead of print.
SARS-CoV-2 reinfection associates with unstable housing and occurs in the presence of antibodies


David J Bean[SUP] 1 [/SUP], Janet Monroe[SUP] 2 [/SUP], Jacquelyn Turcinovic[SUP] 1 [/SUP], Yvetane Moreau[SUP] 2 [/SUP], John H Connor[SUP] 1 [/SUP], Manish Sagar[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: The factors associated with severe acute respiratory coronavirus 2 (SARS-CoV-2) reinfection remain poorly defined.
Methods: We identified patients with SARS-CoV-2 infection and at least one repeat reverse transcription (RT) - polymerase chain reaction (PCR) result a minimum of 90 days after the initial positive test and prior to January 21, 2021. Those with a repeat positive test were deemed to have reinfection (n = 75), and those with only negative tests were classified as convalescents (n = 1,594). Demographics, coronavirus disease 2019 (COVID-19) severity, and treatment histories were obtained from the Boston Medical Center electronic medical record. Humoral responses were analyzed using SARS-CoV-2 specific enzyme linked immunosorbent assays and pseudovirus neutralizations in subset of reinfection (n = 16) and convalescent samples (n = 32). Univariate, multivariate, and time to event analyses were used to identify associations.
Results: Individuals with reinfection had more frequent testing at shorter intervals compared to the convalescents. Unstable housing was associated with more than two-fold greater chance of reinfection. Pre-existing comorbidities and COVID-19 severity after the initial infection were not associated with reinfection. SARS-CoV-2 IgG levels and pseudovirus neutralization were not different within the early weeks after primary infection and at a time-point at least 90 days later in the two groups. In the convalescents, but not in those with reinfection, the late as compared to early humoral responses were significantly higher.
Conclusions: Reinfection associates with unstable housing, which is likely a marker for virus exposure, and reinfection occurs in the presence of SARS-CoV-2 antibodies.

Keywords: SARS-CoV-2; antibody neutralization; homeless; persistent shedding; reinfection.
 
Back
Top Bottom